filmov
tv
Secondary bile duct cancer after chemotherapy
Показать описание
Institute of Pathology & Laboratory Medical Sci
Рекомендации по теме
0:01:00
Secondary bile duct cancer after chemotherapy
0:04:51
BIle Duct Cancer (Cholangiocarcinoma), Causes, Signs and Symptoms, Diagnosis and Treatment.
0:06:31
Understanding Cholangiocarcinoma
0:01:27
The Gallbladder and Bile Ducts | Cancer Research UK
0:00:06
Liver Cancer Warning Signs : Don't Ignore These 9 Symptoms!
0:08:15
The Management of Localized Bile Duct Cancer: Chemotherapy is the Standard
0:04:12
Our Stories: A Second Opinion Saves the Life of a Patient with Bile Duct Cancer
0:26:50
AC22 - TOPAZ-1 Trial in Biliary Tract Cancer
0:02:12
Dr. Primrose on Adjuvant Capecitabine For Biliary Tract Cancer
0:01:48
Gallbladder removal exacerbates colon cancer by elevating levels of a secondary bile acid
0:01:32
Hepatic Artery Infusion (HAI) Pump Chemotherapy for Liver Metastases
0:03:18
Real-world outcomes of patients with intrahepatic CCA treated with trans-arterial radioembolization
2:42:25
Challenges and Opportunities for Treating Intrahepatic Cholangiocarcinoma
0:02:45
Is Bile Duct Cancer a VA Presumptive Disease?
1:27:19
Embracing the Era of Individualized Therapy in Advanced Biliary Cancers
0:02:53
Life after Liver Cancer: The Start of a Second Chance
0:37:22
2016 CCF Annual Conference #4 - Day 1 - What is a Bile Duct?
0:24:46
What is new in bile duct cancer in the last 12 months?
0:00:55
Types of Liver Cancer
0:14:57
Extrahepatic Cholangiocarcinoma: What the Surgeon Needs to Know
0:17:47
YONG CHA, MD, PhD SBRTs Evolving Role in Local Management in Primary and Secondary Liver Cancers
0:57:03
Cholangiocarcinoma: Bridging the Gap Between the Clinic and the Laboratory
0:19:28
Novel Agents and Targets in Biliary Cancer
0:12:33
AC21 - Shubham Pant: Targeting HER2 in Biliary Tract Cancers
welcome to shbcf.ru
0:01:00
0:04:51
0:06:31
0:01:27
0:00:06
0:08:15
0:04:12
0:26:50
0:02:12
0:01:48
0:01:32
0:03:18
2:42:25
0:02:45
1:27:19
0:02:53
0:37:22
0:24:46
0:00:55
0:14:57
0:17:47
0:57:03
0:19:28
0:12:33